Cytopathology of Neuroendocrine Neoplasms of Pancreas & GI Tract; Current Concepts & Controversies
Michelle D. Reid, MD, MS
Emory University Hospital
Neuroendocrine neoplasms of the pancreas and gastrointestinal tract are diverse tumors with variable cytomorphology and grades. While the cytologic diagnosis of classical examples is straightforward, exceptions exist that create challenges in diagnosis and distinction from key differentials. This webinar will explore the cytomorphologic repertoire of well-differentiated neuroendocrine tumors and poorly-differentiated neuroendocrine carcinoma with emphasis on morphologic pitfalls, grading methodologies and distinguishing features from frequent mimics. Additionally, pitfalls and limitations of cytology and ancillary testing in diagnosis and grading will be explored as well as tumor nomenclature at metastatic sites, wording of reports and handling of grade-discordant and ambiguous cases.
This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.
- Recognize the extensive cytomorphologic repertoire of well-differentiated neuroendocrine tumors and poorly differentiated neuroendocrine carcinoma
- Distinguish neuroendocrine tumors from common mimics using morphology and ancillary studies
- Utilize the most accurate and reproducible methodologies to grade these tumors on cytology
- Accurately word cytology reports encompassing classical, grade-discordant and ambiguous cases
Current ACCME guidelines state that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Therefore, it is the policy of the ASC to insure balance, independence, objectivity, and scientific rigor in all its educational programs. All planning individuals participating in any ASC Educational Activity are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. Click here for a complete list.
Michelle D. Reid, MD, MS
The presenter has no conflicts of interest or financial relationships to disclose.
ACCREDITATION AND DESIGNATION STATEMENTS
Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Cytopathology designates this enduring educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Board of Pathology Maintenance of Certification (MOC)
This product can help fulfill the CME requirements and Self-Assessment Modules (SAMs) mandated by the American Board of Pathology Maintenance of Certification (MOC) process. Earn up to 2.0 SAM Credit Hours.
Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 2.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians. The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Cytotechnologists with Licenses in Florida and California
This program is approved for 2 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the live presentation date.
- 2.00 AMA PRA Category 1 Credit™
- 1.00 California Credits
- 2.00 CMLE
- 2.00 Florida Credits
- 2.00 MOC II
- 2.00 Participant